ARTA
IMMU

A.R.T. Advisors’s Immunomedics Inc IMMU Stock Holding History

A.R.T. Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-41,802
Closed -$580K – 1867
2019
Q2 		$580K Buy
41,802
+27,500
+192% +$414K 0.03% 686
2019
Q1 		$275K Buy
+14,302
New +$231K 0.02% 972
2018
Q4 		– Sell
-85,413
Closed -$1.78M – 1816
2018
Q3 		$1.78M Buy
+85,413
New +$2.02M 0.08% 332
2018
Q2 		– Sell
-49,100
Closed -$717K – 1910
2018
Q1 		$717K Buy
+49,100
New +$802K 0.03% 796
2017
Q4 		– Sell
-122,500
Closed -$1.71M – 1795
2017
Q3 		$1.71M Buy
+122,500
New +$1.22M 0.09% 327
2017
Q2 		– Sell
-88,900
Closed -$575K – 1858
2017
Q1 		$575K Buy
+88,900
New +$450K 0.03% 766
2016
Q4 		– Sell
-12,100
Closed -$39K – 1450
2016
Q3 		$39K Buy
+12,100
New +$33.8K 0.01% 601
2016
Q2 		– Sell
-161,193
Closed -$402K – 1749
2016
Q1 		$402K Buy
+161,193
New +$363K 0.02% 937
2013
Q3 		– Sell
-86,905
Closed -$472K – 1571
2013
Q2 		$472K Buy
+86,905
New +$285K 0.02% 899

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

A.R.T. Advisors's IMMU Position: Q3 2019 in Review

A.R.T. Advisors sold out of Immunomedics Inc (IMMU) in Q3 2019, closing a stake of 41,802 shares — an estimated $580K sold.

A.R.T. Advisors first reported a position in IMMU in Q2 2013 and held it in 9 quarters. The position peaked at $1.78M in Q3 2018. 208 funds tracked by Wall St. Rank hold IMMU as of Q3 2019.

  • A.R.T. Advisors reported no remaining Immunomedics Inc position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 41,802 Immunomedics Inc shares in Q3 2019, an estimated $580K.
  • A.R.T. Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 9 quarters.
  • A.R.T. Advisors's Immunomedics Inc position peaked at $1.78M in Q3 2018.
  • 208 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.